3E0J8U1 ICD-10-PCS Code: Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
Introduction of Nonaut Pancr Islet into Bil/Panc Tract, Endo
Axis Breakdown
Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.
| Position | Value | Meaning |
|---|---|---|
| 1 | Section3 | Administration |
| 2 | Body SystemE | Physiological Systems and Anatomical Regions |
| 3 | Root Operation0 | Introduction Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| 4 | Body System / RegionJ | Biliary and Pancreatic Tract |
| 5 | Approach8 | Via Natural or Artificial Opening Endoscopic |
| 6 | SubstanceU | Pancreatic Islet Cells |
| 7 | Qualifier1 | Nonautologous |
MS-DRG Grouper Relationships (FY2026)
Potential MS-DRG participation — not a DRG assignment.
The MS-DRG grouper treats this as a non-operating-room procedure. It appears in the surgical logic of 3 MS-DRGs:
From the CMS MS-DRG Definitions Manual, Appendix E. Actual DRG assignment depends on the complete claim.
Related Codes
Same operation — other Approach
Same table and root operation, differing only in the approach character.
3E0J3U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach, 3E0J7U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
Same operation — other Qualifier
Same table and root operation, differing only in the qualifier character.
Same procedure category (CCSR), other tables
AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.
30243U3 — Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243U4 — Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243X0 — Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach, 30243X2 — Transfusion of Allogeneic Related Cord Blood Stem Cells into Central Vein, Percutaneous Approach, 30243X3 — Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Central Vein, Percutaneous Approach, 30243X4 — Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Central Vein, Percutaneous Approach, 30243Y0 — Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243Y2 — Transfusion of Allogeneic Related Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243Y3 — Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243Y4 — Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, XW020D8 — Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8, XW033DA — Introduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW1337A — Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW133B8 — Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133C8 — Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133F8 — Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133G8 — Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133H9 — Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW133J8 — Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133SB — Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11, +30 more
Contextual Map
Every relationship of 3E0J8U1 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
PCS table
- 3E0[PCS table]
- Administration — Section: Administration[Section]: “Administration”
- Physiological Systems and Anatomical Regions — Body System: Physiological Systems and Anatomical Regions[Body System]: “Physiological Systems and Anatomical Regions”
- Introduction — Operation: Introduction[Operation]: “Introduction”
MS-DRG participation
- DRG 673 — OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC[MS-DRG]: “OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC — Other Kidney and Urinary Tract Procedures (MDC 11)”
- DRG 674 — OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC[MS-DRG]: “OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC — Other Kidney and Urinary Tract Procedures (MDC 11)”
- DRG 675 — OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC[MS-DRG]: “OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC — Other Kidney and Urinary Tract Procedures (MDC 11)”
Clinical classification (CCSR)
- ADM011 — Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells[CCSR category]: “Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells — Administration of Therapeutic Substances”
MDC crossing · diagnoses (721)
- MDC 11 — Diseases and Disorders of the Kidney and Urinary Tract[MDC crossing]: “Diseases and Disorders of the Kidney and Urinary Tract — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs.”
- A18.10 — Tuberculosis of genitourinary system, unspecified[Same-MDC diagnosis]: “Tuberculosis of genitourinary system, unspecified — grouped in MDC 11, the diagnosis side of this code's crossing.” · Check 3E0J8U1 + A18.10 together
- A18.11 — Tuberculosis of kidney and ureter[Same-MDC diagnosis]: “Tuberculosis of kidney and ureter — grouped in MDC 11, the diagnosis side of this code's crossing.” · Check 3E0J8U1 + A18.11 together
- A18.12 — Tuberculosis of bladder[Same-MDC diagnosis]: “Tuberculosis of bladder — grouped in MDC 11, the diagnosis side of this code's crossing.” · Check 3E0J8U1 + A18.12 together
- A18.13 — Tuberculosis of other urinary organs[Same-MDC diagnosis]: “Tuberculosis of other urinary organs — grouped in MDC 11, the diagnosis side of this code's crossing.” · Check 3E0J8U1 + A18.13 together
- A36.85 — Diphtheritic cystitis[Same-MDC diagnosis]: “Diphtheritic cystitis — grouped in MDC 11, the diagnosis side of this code's crossing.” · Check 3E0J8U1 + A36.85 together
- and 716 more
Nearest codes
- 3E0J3U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach[One axis away]
- 3E0J7U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening[One axis away]
- 3E0J8U0 — Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic[One axis away]
Change history
No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.